# Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion

> **NCT04792970** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 4 (actual)

## Conditions studied

- Malignant Pleural Effusion

## Interventions

- **DRUG:** Talc

## Key facts

- **NCT ID:** NCT04792970
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-18
- **Primary completion:** 2022-10-07
- **Final completion:** 2022-10-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Study enrollment not met
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04792970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04792970, "Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04792970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*